recombinant fowlpox-B7.1 vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016401
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 (rF-B7.1) vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells.
| Identifier | MLC-T-ONC-016401 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rF-B7.1 vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016401",
"term": "recombinant fowlpox-B7.1 vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 (rF-B7.1) vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells.",
"abbreviation": "rF-B7.1 vaccine",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-fowlpox-b7-1-vaccine/"
}
Record 14,142 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.